TMSB10 and breast cancer: Kaplan-Meier survival analysis revealed that patients with high TMSB10 expression had shorter overall survival (P < 0.001; hazard ratio = 3.50, 95% CI = 2.38 to 5.17; Fig. 2c) and distant metastasis-free survival (P < 0.001; hazard ratio = 3.28, 95% CI = 2.28 to 4.73; Fig. 2d), which were consistent with TCGA and Kaplan-Meier Plotter (BC) profiles (Additional file 7: Figure S2b-f).